APP alone activates murine splenocytes, markedly increasing their proliferation and gamma-interferon (IFNc) secretion, and presents no cytotoxicity in vitro. Although murine splenocytes are stimulated by the mitogen concanavalin A (ConA), APP suppresses their proliferation in a dose-dependent manner.